Selegiline improves cardiac sympathetic terminal function and β-adrenergic responsiveness in heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 279, Issue 3 48-3, 2000, Pages

  Shite, Junya ^a   Dong, Erdon ^a   Kawai, Hiroya ^a   Stevens, Suzanne Y ^a   Liang, Chang Seng ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Baroreflex; Hemodynamics; Noradrenergic neurotransmitter profiles

Indexed keywords

BETA ADRENERGIC RECEPTOR; CLONIDINE; CYANOPINDOLOL I 125; ISOPRENALINE; MOXONIDINE; NISOXETINE; NORADRENALIN; PLACEBO; SELEGILINE; TRITIUM;

ADRENERGIC SYSTEM; ANIMAL MODEL; ARTICLE; BRAIN PROTECTION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG EFFECT; HEART FAILURE; NERVE FUNCTION; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RABBIT;

EID: 0033826753     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.279.3.h1283     Document Type: Article

References (51)

1. Cardiac and systemic sympathetic activity in response to clonidine in human heart failure
2. (-)-Deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats
3. (-)-Deprenyl can induce soluble superoxide dismutase in rat striata
4. Cardiovascular changes in response to selective monoamine oxidase inhibition in the rat
5. Neurons in area postrema mediate vasopressin-induced enhancement of the baroreflex
6. Acute hemodynamic and neurohumoral effects of moxonidine in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
7. Cardiac sympathetic nerve function in congestive heart failure
8. Arterial baroreflex abnormalities in heart failure; reversal after orthotopic cardiac transplantation
9. Does a second generation of centrally acting antihypertensive drugs really exist?
10. Effect of clonidine on heart rate variability in congestive heart failure
11. Norepinephrine spillover to plasma in patients with congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nervous activity
12. Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure
13. Short-term effects of naloxone on hemodynamics and baroreflex function in conscious dogs with pacing-induced congestive heart failure
14. Deprenyl and pergolide rescue spinal motor neurons from axotomy-induced neuronal death in the neonatal rat
15. Cardiorespiratory effects of intravenous bolus administration and infusion of ketamine-midazolam in dogs
16. Assessing the effects of deprenyl on longevity and antioxidant defenses in different animal models
17. Upregulation of antioxidant enzyme activities by deprenyl. Implications for life span extension
18. The pharmacology of selegiline ((-)-deprenyl). New aspects
19. Differential changes of myocardial β-adrenoceptor subtypes and G-proteins in dogs with right-sided congestive heart failure
20. Effect of sympathoinhibition on exercise performance in patients with heart failure
21. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction
22. Activity of the sympathetic nervous system and reninangiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure
23. (-)-Deprenyl protection of 1-methyl-4 phenylpyridium ion (MPP+)-induced apoptosis independent of MAO-B inhibition
24. l-Deprenyl potentiates NGF-induced changes in superoxide dismutase mRNA in PC12 cells
25. Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to beta-adrenoceptor downregulation
26. ANG II and baroreflex function in rabbits with CHF and lesions of the area postrema
27. The pharmacology of B-type selective monoamine oxidase inhibitors; milestones in (-)-deprenyl research
28. The neuroprotective and neuronal rescue effects of (-)-deprenyl
29. Chronic sympathetic suppression in the treatment of chronic congestive heart failure
30. Effects of isofluorane on cardiovascular system and sympathovagal balance in New Zealand White rabbits
31. Haemodynamic response to induction of anaesthesia with ketamine/midazolam
32. Analysis of radioligand binding experiments: A collection of computer programs for the IBM PC
33. Baroreflex sensitivity predicts the induction of ventricular arrhythmias by cesium chloride in rabbits
34. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine
35. Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage
36. Left ventricular and myocyte structure and function following chronic ventricular tachycardia in rabbits
37. Mechanism of the sympathoinhibition produced by the clonidine-like drugs rilmenidine and moxonidine
38. Selegiline can mediate neuronal rescue rather than neuronal protection
39. Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration
40. Apoptosis in neurodegenerative disorders: Potential for therapy by modifying gene transcription
41. (-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis
42. (-)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase
43. 3H]nisoxetine: A radioligand for quantitation of norepinephrine uptakes sites by autoradiography or by homogenate binding
44. The effect of l-deprenyl, d-deprenyl, and MDL72974 on mitochondrial respiration: A possible mechanism leading to an adaptative increase in superoxide dismutase activity
45. Restoration of sympathetic noradrenergic nerve fibers in the spleen by low doses of l-deprenyl treatment in young sympathectomized and old Fischer 344 rats
46. Diphenylpiperazines enhance regeneration after facial nerve injury
47. Selegiline diminishes cardiovascular autonomic responses in Parkinson's disease
48. Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: Time course and modification by (-)-deprenyl
49. + in vivo
50. l-Deprenyl, blocking apoptosis and regulating gene expression in cultured retinal neurons
51. Suppressing sympathetic activation with clonidine on ventricular arrhythmias in congestive heart failure